drugset / Trial / NCT00389935
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Phase 2
Completed
14 enrolled
Northport Veterans Affairs Medical Center
Augusta University · collabUniversity of Massachusetts, Worcester · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Thalidomide is effective in the treatment of arteriovenous malformations in the gastrointestinal tract.
Timeline
- Start
- 2006-10
- Primary completion
- 2011-06
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | 50 mg | — |
| Subject | Thalidomide | Other / unclassified | 200 mg | — |